As of Nov 19, 2026, 1 of 1 active firms rate HCWB a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HCWB EPS & revenue forecast
EPS · NEXT QUARTER
$-8.34
Range $-8.34 – $-8.34 · 1 analysts · +36% YoY
Next period, 1 analysts expect HCW Biologics Inc to earn $-8.34 a share (range $-8.34 – $-8.34), versus $-6.12 a year earlier. Full-year consensus is $-28.32, growing to $-6.30 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts · -100% YoY
Revenue is expected to reach $0 (range $0 – $0), -100.0% year-over-year. Full-year consensus is $6.7M, rising to $0 next year.
Top analysts covering HCW Biologics Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HCWB.
#1
Michael Okunewitch
Maxim Group
Buy
$30.00+3827.2% to target
Coverage
—
+ Follow
HCWB stock forecast FAQ
What is HCWB's average 12-month price target?+
The 1 active firms with a live target average $5.00 for HCW Biologics Inc over the next 12 months, ranging from a $5.00 high to a $5.00 low, as of Nov 19, 2026.
Is HCWB stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover HCWB?+
1 active firms have a recognized rating on HCW Biologics Inc as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HCWB?+
Among analysts who currently cover HCWB, Michael Okunewitch of Maxim Group has the strongest overall Quantellect track record. Their current call is Buy with a $30.00 target.
What is HCW Biologics Inc's projected EPS for next quarter?+
The consensus estimate is $-8.34 per share (range $-8.34 – $-8.34) across 1 analysts. Full-year EPS is projected at $-28.32, rising to $-6.30 the following year.
How much revenue is HCW Biologics Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $6.7M, growing to $0 next year.
Have analysts been upgrading or downgrading HCWB lately?+
As of Nov 19, 2026, 1 of 1 active firms rate HCWB a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HCWB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.